Surface Financial Statements From 2010 to 2024
| SURFDelisted Stock | USD 0.96 0.03 3.23% |
Check Surface Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surface Oncology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Surface financial statements analysis is a perfect complement when working with Surface Oncology Valuation or Volatility modules.
Surface |
Surface Oncology Company Return On Equity Analysis
Surface Oncology's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Surface Oncology Return On Equity | -1.06 |
Most of Surface Oncology's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surface Oncology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Surface Oncology has a Return On Equity of -1.0578. This is 95.59% lower than that of the Biotechnology sector and 97.1% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Surface Oncology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Surface Oncology's current stock value. Our valuation model uses many indicators to compare Surface Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surface Oncology competition to find correlations between indicators driving Surface Oncology's intrinsic value. More Info.Surface Oncology is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Surface Oncology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Surface Oncology Financial Statements
Surface Oncology stakeholders use historical fundamental indicators, such as Surface Oncology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Surface Oncology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Surface Oncology's assets and liabilities are reflected in the revenues and expenses on Surface Oncology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Surface Oncology. Please read more on our technical analysis and fundamental analysis pages.
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Surface Oncology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Surface Stock
If you are still planning to invest in Surface Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surface Oncology's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |